ArticleFrontiers in immunology2024

Leveraging single-cell and multi-omics approaches to identify MTOR-centered deubiquitination signatures in esophageal cancer therapy.

Kang Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.